Press Releases
WASHINGTON, DC - Today, Congressman David Schweikert announced the FY 2021 National Defense Authorization Act conference report includes his legislation, H.R.
WASHINGTON, DC - Today, Congressman David Schweikert joined 48 lawmakers in calling for the expansion of access to telehealth services during the COVID-19 pandemic to be made permanent.
WASHINGTON, DC - Today, Congressman David Schweikert (AZ-06) announced the departure of his Chief of Staff Katherina Dimenstein, who has served as Schweikert’s longtime senior aide, at the end of this week.
WASHINGTON, DC - Today, Congressman David Schweikert (AZ-06) released the following statement applauding introduction of H.R. 14, House Republicans Commitment to Defeat the Virus and Keep America Healthy Act.
WASHINGTON, DC - Today, Congressman David Schweikert (AZ-06) released the following statement applauding the introduction of the Securing a Strong Retirement Act of 2020, bipartisan legislation from the Ways and Means Committee that builds upon the SECURE Act, which became law in 2019.
WASHINGTON, DC - Representative David Schweikert joined Representatives Annie Kuster (D-NH), David McKinley (R-WV), Paul Tonko (D-NY), Anthony Gonzalez (R-OH), Scott Peters (D-CA), Jeff Fortenberry (R-NE), Tom O’Halleran (D-AZ), and Diana DeGette (D-CO) in introducing the Carbon Removal, Efficient Agencies, Technology Expertise (CREATE) Act.
WASHINGTON, DC - Today, Congressmen David Schweikert (AZ-06), Bobby Rush (IL-01), Mike Kelly (PA-16), and Mike Thompson (CA-05) announced the introduction of the Safe Testing at Residence Telehealth (START) Act. This bipartisan legislation would provide robust at-home COVID-19 testing for seniors and other vulnerable populations
WASHINGTON, DC - Today, Congressman David Schweikert (AZ-06) led a bipartisan letter with the Arizona delegation to the Centers for Medicare and Medicaid Services (CMS) to review their Extreme ad Uncontrollable Circumstances policy.
WASHINGTON, DC - Today, Congressman David Schweikert (AZ-06) released the following statement applauding the National Institute of Allergy and Infectious Diseases (NIAID) for taking action towards funding the Coccidioidomycosis Collaborative Research Centers (CCRC) program, aimed to provide extended research for the improved diagnosis, treatment and prevention of Valley F
